Intra-Arterial Delivery of Bevacizumab after Blood-Brain Barrier Disruption for the Treatment of Recurrent Glioblastoma: Progression-Free Survival and Overall Survival

BACKGROUND: This prospective, single-center study assesses progression-free survival (PFS) and overall survival (OS) in patients with recurrent glioblastoma multiforme (GBM) treated with a single dose of superselective intra-arterial cerebral infusion (SIACI) of bevacizumab (BV) after blood-brain ba...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Burkhardt, Jan-Karl, Riina, Howard, Shin, Benjamin J., Christos, Paul, Kesavabhotla, Kartik, Hofstetter, Christoph P., Tsiouris, Apostolos John, Boockvar, John A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3743246/
https://ncbi.nlm.nih.gov/pubmed/22405392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.wneu.2011.05.056
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados